Cargando…
Angiotensin-Converting Enzyme Inhibitors and Active Tuberculosis: A Population-Based Study
Numerous epidemiological data suggest that the use of angiotensin-converting enzyme inhibitors (ACEis) can improve the clinical outcomes of pneumonia. Tuberculosis (TB) is an airborne bacteria like pneumonia, and we aimed to find out whether the use of ACEis can decrease the risk of active TB. We co...
Autores principales: | Wu, Jiunn-Yih, Lee, Meng-Tse Gabriel, Lee, Si-Huei, Lee, Shih-Hao, Tsai, Yi-Wen, Hsu, Shou-Chien, Chang, Shy-Shin, Lee, Chien-Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902497/ https://www.ncbi.nlm.nih.gov/pubmed/27175655 http://dx.doi.org/10.1097/MD.0000000000003579 |
Ejemplares similares
-
Risk of gastrointestinal perforation in patients taking oral fluoroquinolone therapy: An analysis of nationally representative cohort
por: Hsu, Shou-Chien, et al.
Publicado: (2017) -
Risk of incident active tuberculosis disease in patients treated with non-steroidal anti-inflammatory drugs: a population-based study
por: Wu, Chun-Wei, et al.
Publicado: (2017) -
Plasma Biomarkers Can Predict Treatment Response in Tuberculosis Patients: A Prospective Observational Study
por: Lee, Meng-Rui, et al.
Publicado: (2015) -
Treatment of chronic hepatitis C regiments containing with recombinant interferon in patients with sustained virological response predicts risk of hepatocellular carcinoma: A meta-analysis
por: Li, Chien-Feng, et al.
Publicado: (2020) -
Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan
por: Huang, Shiou-Huei, et al.
Publicado: (2012)